Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett-Mayer

Showing results (11-20 of 289) with videos related to

Pageof 29
Sort By:
Clinical Trials (London, England)|October 29, 2014
A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designsCody Chiuzan, Elizabeth Garrett-Mayer, Sharon D Yeatts
Archives of General Psychiatry|July 4, 2007
Social and communication development in toddlers with early and later diagnosis of autism spectrum disordersRebecca J Landa, Katherine C Holman, Elizabeth Garrett-Mayer
Statistics in Medicine|November 17, 2022
Explicit underdose control based on toxicity: Four points to considerPaul H Frankel, Elizabeth Garrett-Mayer, Mark D Krailo
Contemporary Clinical Trials|December 18, 2022
Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trialsNathaniel S O'Connell, Nolan A Wages, Elizabeth Garrett-Mayer
Statistics in Medicine|February 24, 2011
Proportional odds model for dose-finding clinical trial designs with ordinal toxicity gradingEmily M Van Meter, Elizabeth Garrett-Mayer, Dipankar Bandyopadhyay
Physiological Measurement|December 19, 2013
Dynamics of tissue shrinkage during ablative temperature exposuresChristian Rossmann, Elizabeth Garrett-Mayer, Frank Rattay, et al.
CBE Life Sciences Education|February 13, 2015
The faculty costs to educate a biomedical sciences graduate studentAdam J Smolka, Perry V Halushka, Elizabeth Garrett-Mayer
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 14, 2010
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VREJohn B Bossaer, Philip D Hall, Elizabeth Garrett-Mayer
Clinical Trials (London, England)|May 2, 2012
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment methodEmily M Van Meter, Elizabeth Garrett-Mayer, Dipankar Bandyopadhyay
Clinical Trials (London, England)|April 24, 2024
Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsiesLaura A Levit, Elizabeth Garrett-Mayer, Jeffrey Peppercorn, et al.
Pageof 29

Showing results (11-20 of 289) with videos related to

Sort By:
Pageof 29
Clinical Trials (London, England)|October 29, 2014
A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designsCody Chiuzan, Elizabeth Garrett-Mayer, Sharon D Yeatts
Archives of General Psychiatry|July 4, 2007
Social and communication development in toddlers with early and later diagnosis of autism spectrum disordersRebecca J Landa, Katherine C Holman, Elizabeth Garrett-Mayer
Statistics in Medicine|November 17, 2022
Explicit underdose control based on toxicity: Four points to considerPaul H Frankel, Elizabeth Garrett-Mayer, Mark D Krailo
Contemporary Clinical Trials|December 18, 2022
Quasi-partial order continual reassessment method: Applying toxicity scores to cancer dose-finding drug combination trialsNathaniel S O'Connell, Nolan A Wages, Elizabeth Garrett-Mayer
Statistics in Medicine|February 24, 2011
Proportional odds model for dose-finding clinical trial designs with ordinal toxicity gradingEmily M Van Meter, Elizabeth Garrett-Mayer, Dipankar Bandyopadhyay
Physiological Measurement|December 19, 2013
Dynamics of tissue shrinkage during ablative temperature exposuresChristian Rossmann, Elizabeth Garrett-Mayer, Frank Rattay, et al.
CBE Life Sciences Education|February 13, 2015
The faculty costs to educate a biomedical sciences graduate studentAdam J Smolka, Perry V Halushka, Elizabeth Garrett-Mayer
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 14, 2010
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VREJohn B Bossaer, Philip D Hall, Elizabeth Garrett-Mayer
Clinical Trials (London, England)|May 2, 2012
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment methodEmily M Van Meter, Elizabeth Garrett-Mayer, Dipankar Bandyopadhyay
Clinical Trials (London, England)|April 24, 2024
Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsiesLaura A Levit, Elizabeth Garrett-Mayer, Jeffrey Peppercorn, et al.
Pageof 29